Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | +8618964387627 |
| E-mail: | customer_service@efebio.com |
| QQ: | 3012643761 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Tasipimidine sulfate | C13H18N2O6S | 1465908-73-9 | Details |
| JG26 | C19H22Br2N4O6S | 1464910-32-4 | Details |
| Ebalzotan | C19H30N2O2 | 149494-37-1 | Details |
| EIF2α activator 2 | C21H20F6N2O2 | 1501618-04-7 | Details |
| Ontazolast | C21H25N3O | 147432-77-7 | Details |
| EMD57439 | C22H23N3O4S | 148714-88-9 | Details |
| Mal-L-PA-NH-Boc | C12H16N2O6 | 1491152-23-8 | Details |
| AGI-14100 | C29H22ClF4N5O3 | 1448346-43-7 | Details |
| VU0467485 | C17H17FN4O2S | 1451994-10-7 | Details |
| Brontictuzumab | 1447814-75-6 | Details |
| Letolizumab | 1450981-87-9 | Details |
| Zolbetuximab | 1496553-00-4 | Details |
| RU 47213 | C14H15ClN2O3 | 145071-44-9 | Details |
| (±)-N-Methylcoclaurine | C18H21NO3 | 1472-62-4 | Details |
| L-162,313 | C30H38N4O4S2 | 151488-11-8 | Details |
| CPS-11 | C14H12N2O5 | 145945-21-7 | Details |
| Ansornitinib | C30H32N6O4 | 1448874-96-1 | Details |
| Nicanartine | C23H33NO2 | 150443-71-3 | Details |
| HDAC3-IN-T247 | C21H19N5OS | 1451042-18-4 | Details |
| Lumretuzumab | 1448327-63-6 | Details |
| Lilotomab | 1453362-55-4 | Details |
| Ascrinvacumab | 1463459-96-2 | Details |
| Crotedumab | 1452387-69-7 | Details |
| S1R agonist 2 | C21H27NO | 150085-21-5 | Details |
| BIRM 271 | C21H25N3O | 149106-77-4 | Details |
| Pomisartan | C31H30N4O2 | 144702-17-0 | Details |
| Napitane | C22H25NO2 | 148152-63-0 | Details |
| IMP2-IN-2 | C22H19F3N2O3S | 1448353-39-6 | Details |
| (S)-Vamicamide | C18H23N3O | 151851-72-8 | Details |
| Asp-Asp-Asp-Asp-Asp-Asp | C24H32N6O19 | 145224-96-0 | Details |
| Repinotan | C21H24N2O4S | 144980-29-0 | Details |
| BRD56491 | C20H14O2 | 14756-26-4 | Details |
| Uprifosbuvir | C22H29ClN3O9P | 1496551-77-9 | Details |
| 6-Prenylquercetin-3-methylether | C21H20O7 | 151649-34-2 | Details |
| Indusatumab vedotin | 1514889-12-3 | Details |
| FPI-1523 sodium | C9H15N4NaO7S | 1452459-52-7 | Details |
| Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
| Amgen-23 | C23H25Cl2N3O2S | 1448706-15-7 | Details |
| Decoquinate-d5 | C24H35NO5 | 1453100-61-2 | Details |
| TFP-PEG3-TFP | C22H18F8O7 | 1446282-34-3 | Details |
| Cyclo(L-leucyl-L-valyl) | C11H20N2O2 | 15136-24-0 | Details |
| Taletrectinib free base | C23H24FN5O | 1505514-27-1 | Details |
| Istiratumab | 1509928-04-4 | Details |
| Tomaralimab | 1449294-76-1 | Details |
| SMN-C2 | C24H27N5O2 | 1446311-56-3 | Details |
| Zaloglanstat | C21H20ClF3N4O2 | 1513852-12-4 | Details |
| Detumomab | 145832-33-3 | Details |
| Efletirizine | C21H24F2N2O3 | 150756-35-7 | Details |
| Fipamezole | C14H15FN2 | 150586-58-6 | Details |
| OPC18750 HCl | C20H22N2O4.ClH | 145364-90-5 | Details |
| EMD57033 | C22H23N3O4S | 147527-31-9 | Details |
| Boeravinone O | C17H12O7 | 1449384-21-7 | Details |
| CEP-40125 | C28H45Cl2N3O2 | 1456608-94-8 | Details |
| Jasamplexoside C | C42H54O25 | 147742-02-7 | Details |
| BMS-986141 | C27H23N5O5S2 | 1478711-48-6 | Details |
| GSK-3β inhibitor 3 | C18H14FNO2S | 1448990-73-5 | Details |
| Icopezil | C23H25N3O2 | 145508-78-7 | Details |
| Lefradafiban | C23H25N3O6 | 149503-79-7 | Details |
| Xemilofiban | C18H22N4O4 | 149820-74-6 | Details |
| 2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv | C25H34F2O6 | 144459-71-2 | Details |
| Priliximab | 147191-91-1 | Details |
| 2'',3''-Dihydro-3',3'''-biapigenin | C30H20O10 | 151455-25-3 | Details |
| BAY-826 | C26H19F5N6OS | 1448316-08-2 | Details |
| S-15535 | C21H24N2O2 | 146998-34-7 | Details |
| Mefuparib hydrochloride | C17H16ClFN2O2 | 1449746-00-2 | Details |
| Vanucizumab | 1448221-05-3 | Details |
| Andecaliximab | 1518996-49-0 | Details |
| Nemolizumab | 1476039-58-3 | Details |
| Trimebutine CTB salt | C29H36N2O8S2 | 1456509-46-8 | Details |
| Scutellarin-7-diglucosidic acid | C27H26O18 | 150641-65-9 | Details |
| α-Amylase-IN-1 | C18H18N2O3 | 148404-10-8 | Details |
| DB772 | C20H17ClN4O | 1451058-50-6 | Details |
| Triperiden | C21H30ClNO | 14617-17-5 | Details |
| Ly-295501 | C15H12Cl2N2O4S | 150869-74-2 | Details |
| (Rac)-Sabcomeline | C10H15N3O | 149156-36-5 | Details |
| ClpB-IN-1 | C14H10N2O2S2 | 1453172-23-0 | Details |
| QL-X-138 | C25H19N5O2 | 1469988-63-3 | Details |
| Adatanserin hydrochloride | C21H31N5O. HCl | 144966-96-1 | Details |
| Cergutuzumab amunaleukin | 1509916-03-3 | Details |
| Mirvetuximab soravtansine | 1453084-37-1 | Details |
| Gancotamab | 1509928-00-0 | Details |
| Udonitrectag | C20H19NO5 | 1458063-04-1 | Details |
| 2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxylic acid | C12H9FN2O3 | 1502645-66-0 | Details |
| DP-1 hydrochloride | C26H32ClN5O3 | 1472616-35-5 | Details |
| Ripisartan | C23H22N8O | 148504-51-2 | Details |
| Enfortumab | 1448664-46-7 | Details |
| Abacavir acetate | C16H20N6O3 | 1446418-48-9 | Details |
| Indusatumab | 1497400-26-6 | Details |
| Bleselumab | 1453067-91-8 | Details |
| Mirvetuximab | 1453084-36-0 | Details |
| Depatuxizumab | 1471999-69-5 | Details |
| E-3620 | C20H27Cl2N3O2 | 151213-86-4 | Details |
| IMP2-IN-1 | C21H14F3NO4 | 1480482-51-6 | Details |
| Niazinin | C15H21NO6S | 147821-57-6 | Details |
| TML-6 | C30 H37 N O7 | 1462868-88-7 | Details |
| Emactuzumab | 1448221-67-7 | Details |
| Elgemtumab | 1512559-37-3 | Details |
| Isatuximab | 1461640-62-9 | Details |
| Bz-(Me)Tz-NHS | C19H20N6O5 | 1454558-58-7 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||